EPGL Medical Unveils New Devices and Intellectual Property Under EP Global Communications, Inc. Ownership
IRVINE, Jun 18, 2013 (GLOBE NEWSWIRE via COMTEX) - via PRWEB - EP Global Communications, Inc. (the Company), (Stock Ticker: EPGL) EPGL Medical Sciences, is pleased to announce several new devices resulting from the TopSpin technology recently announced. Many of these devices have not been revealed before today. To Compliment the MPDD, the new MPTT will be first to become a prototype this fall and new FDA 510k and PMA Applications are being prepared for filing during 3rd and 4th Quarters. EPGL has filed patents and owns unique Intellectual Property for each of the following new smart medical devices:
1. A new advanced ablation device for nerve pain treatment in the back.
2. A new advanced ablation device for nerve treatment of Facial Glabballar Frowning.
3. A new advanced device for elimination of facial wrinkles.
4. A new advanced Epidural device.
5. A new advanced power source for TopSpin medical devices.
6. A new and promising device for treatment of Retinitis Pigmentosa
7. A new and promising device for treatment of Macular Degeneration
8. A new and promising treatment for Hearing Loss
9. A new more accurate treatment for trigger points in the muscles (MPTT)
10. A new advanced device for treatment of prostate tumors.
11. A new advanced endoscopic device.
12. A new advanced device for delivery of micron sized drug payloads.
